Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 155

    1.

    Prophylaxis for occupational exposure to HIV.

    Gerberding JL.

    Ann Intern Med. 1996 Sep 15;125(6):497-501. Review.PMID: 8779463 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Occupational exposure to HIV and post-exposure prophylaxis in healthcare workers.

    Kennedy I, Williams S.

    Occup Med (Lond). 2000 Aug;50(6):387-91. Review.PMID: 10994239 [PubMed - indexed for MEDLINE]Related articles

    3.

    Tolerability of postexposure antiretroviral prophylaxis for occupational exposures to HIV.

    Lee LM, Henderson DK.

    Drug Saf. 2001;24(8):587-97. Review.PMID: 11480491 [PubMed - indexed for MEDLINE]Related articles

    4.

    Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

    Brocklehurst P, Volmink J.

    Cochrane Database Syst Rev. 2002;(2):CD003510. Review. Update in: Cochrane Database Syst Rev. 2007;(1):CD003510. PMID: 12076484 [PubMed - indexed for MEDLINE]Related articles

    5.

    PHS recommends preventive drugs for HIV exposures.

    [No authors listed]

    OR Manager. 1996 Aug;12(8):1, 6. No abstract available. PMID: 10161372 [PubMed - indexed for MEDLINE]Related articles

    6.

    Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.

    Brocklehurst P, Volmink J.

    Cochrane Database Syst Rev. 2002;(1):CD003510. Review. Update in: Cochrane Database Syst Rev. 2002;(2):CD003510. PMID: 11869666 [PubMed - indexed for MEDLINE]Related articles

    7.

    Prophylaxis of HIV infection following occupational exposure.

    Fish DN.

    Ann Pharmacother. 1993 Oct;27(10):1243-56. Review.PMID: 8251695 [PubMed - indexed for MEDLINE]Related articles

    8.

    Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.

    Staszewski S, Morales-Ramirez J, Tashima KT, Rachlis A, Skiest D, Stanford J, Stryker R, Johnson P, Labriola DF, Farina D, Manion DJ, Ruiz NM.

    N Engl J Med. 1999 Dec 16;341(25):1865-73.PMID: 10601505 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.

    Pinkerton SD, Holtgrave DR, Pinkerton HJ.

    Arch Intern Med. 1997 Sep 22;157(17):1972-80.PMID: 9308509 [PubMed - indexed for MEDLINE]Related articles

    10.

    Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.

    Bhana N, Ormrod D, Perry CM, Figgitt DP.

    Paediatr Drugs. 2002;4(8):515-53. Review.PMID: 12126455 [PubMed - indexed for MEDLINE]Related articles

    12.

    Clinicians experiment with post-exposure drug pairs.

    [No authors listed]

    AIDS Alert. 1996 Feb;11(2):16-7.PMID: 11363233 [PubMed - indexed for MEDLINE]Related articles

    13.

    A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

    Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, Eron JJ Jr, Feinberg JE, Balfour HH Jr, Deyton LR, Chodakewitz JA, Fischl MA.

    N Engl J Med. 1997 Sep 11;337(11):725-33.PMID: 9287227 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Antiviral chemoprophylaxis after occupational exposure to human immunodeficiency virus: why, when, where, and what.

    Landers MB 3rd, Fraser VJ.

    Am J Ophthalmol. 1997 Aug;124(2):234-9.PMID: 9262549 [PubMed - indexed for MEDLINE]Related articles

    15.

    Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.

    Staszewski S, Keiser P, Montaner J, Raffi F, Gathe J, Brotas V, Hicks C, Hammer SM, Cooper D, Johnson M, Tortell S, Cutrell A, Thorborn D, Isaacs R, Hetherington S, Steel H, Spreen W; CNAAB3005 International Study Team.

    JAMA. 2001 Mar 7;285(9):1155-63. Erratum in: JAMA 2001 Jun 13;285(22):2858. PMID: 11231744 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.

    Suksomboon N, Poolsup N, Ket-Aim S.

    J Clin Pharm Ther. 2007 Jun;32(3):293-311. Review.PMID: 17489882 [PubMed - indexed for MEDLINE]Related articles

    17.

    A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.

    Cardo DM, Culver DH, Ciesielski CA, Srivastava PU, Marcus R, Abiteboul D, Heptonstall J, Ippolito G, Lot F, McKibben PS, Bell DM.

    N Engl J Med. 1997 Nov 20;337(21):1485-90.PMID: 9366579 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Molecular biological assessment methods and understanding the course of the HIV infection.

    Katzenstein TL.

    APMIS Suppl. 2003;(114):1-37. Review.PMID: 14626050 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Post-exposure HIV prevention within and outside the hospital]

    Jost J.

    Ther Umsch. 1998 May;55(5):289-94. Review. German. PMID: 9643126 [PubMed - indexed for MEDLINE]Related articles

    20.

    Update: provisional Public Health Service recommendations for chemoprophylaxis after occupational exposure to HIV.

    Centers for Disease Control and Prevention (CDC).

    MMWR Morb Mortal Wkly Rep. 1996 Jun 7;45(22):468-80.PMID: 8622618 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data